109 related articles for article (PubMed ID: 9815720)
1. Cathepsin D and dynamic magnetic resonance imaging gadolinium enhancement in malignant and benign breast lesions.
Stomper PC; Winston JS; Herman S; Klippenstein DL; Blumenson LE
Clin Cancer Res; 1997 Apr; 3(4):559-63. PubMed ID: 9815720
[TBL] [Abstract][Full Text] [Related]
2. Invasive breast carcinoma: analysis of dynamic magnetic resonance imaging enhancement features and cell proliferative activity determined by DNA S-phase percentage.
Stomper PC; Herman S; Klippenstein DL; Winston JS; Budnick RM; Stewart CC
Cancer; 1996 May; 77(9):1844-9. PubMed ID: 8646683
[TBL] [Abstract][Full Text] [Related]
3. Cathepsin-D expression in breast lesion: an immunohistochemical study.
Brujan I; Mărgăritescu C; Simionescu C; Pirici D; Fronie A; Foarfă C; Stepan A; Vrabete M
Rom J Morphol Embryol; 2009; 50(1):31-9. PubMed ID: 19221643
[TBL] [Abstract][Full Text] [Related]
4. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin-D in human breast cancer: correlation with vascular invasion and other clinical and histopathological characteristics.
Hähnel R; Harvey J; Robbins P; Sterrett G
Anticancer Res; 1993; 13(6A):2131-5. PubMed ID: 8297125
[TBL] [Abstract][Full Text] [Related]
6. Expression of E-cadherin, beta-catenin, cathepsin D, gelatinases and their inhibitors in invasive ductal breast carcinomas.
Zhang YG; DU J; Tian XX; Zhong YF; Fang WG
Chin Med J (Engl); 2007 Sep; 120(18):1597-605. PubMed ID: 17908479
[TBL] [Abstract][Full Text] [Related]
7. Pathologic correlates of false positive breast magnetic resonance imaging findings: which lesions warrant biopsy?
Langer SA; Horst KC; Ikeda DM; Daniel BL; Kong CS; Dirbas FM
Am J Surg; 2005 Oct; 190(4):633-40. PubMed ID: 16164938
[TBL] [Abstract][Full Text] [Related]
8. Frequency of malignancy in lesions classified as probably benign after dynamic contrast-enhanced breast MRI examination.
Sadowski EA; Kelcz F
J Magn Reson Imaging; 2005 May; 21(5):556-64. PubMed ID: 15834907
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T.
Lo GG; Ai V; Chan JK; Li KW; Cheung PS; Wong TT; Ma M; Lee R; Chien D
J Comput Assist Tomogr; 2009; 33(1):63-9. PubMed ID: 19188787
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin D in invasive ductal NOS, medullary, lobular and mucinous breast carcinoma. An immunohistochemical study.
Bedner E; Harezga B; Osborn M; Domagała W
Pol J Pathol; 1995; 46(1):11-5. PubMed ID: 7780691
[TBL] [Abstract][Full Text] [Related]
11. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features.
Stomper PC; Herman S; Klippenstein DL; Winston JS; Edge SB; Arredondo MA; Mazurchuk RV; Blumenson LE
Radiology; 1995 Nov; 197(2):387-95. PubMed ID: 7480682
[TBL] [Abstract][Full Text] [Related]
12. Two different types of ring-like enhancement on dynamic MR imaging in breast cancer: correlation with the histopathologic findings.
Kobayashi M; Kawashima H; Matsui O; Zen Y; Suzuki M; Inokuchi M; Noguchi M; Ohta T
J Magn Reson Imaging; 2008 Dec; 28(6):1435-43. PubMed ID: 19025952
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging for axillary staging in patients with breast cancer.
Mortellaro VE; Marshall J; Singer L; Hochwald SN; Chang M; Copeland EM; Grobmyer SR
J Magn Reson Imaging; 2009 Aug; 30(2):309-12. PubMed ID: 19466713
[TBL] [Abstract][Full Text] [Related]
14. The immunohistochemical expression of cathepsin D in colorectal cancer.
Valentini AM; Pirrelli M; Armentano R; Caruso ML
Anticancer Res; 1996; 16(1):77-80. PubMed ID: 8615673
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of benign from malignant breast disease associated with screening detected microcalcifications using dynamic contrast enhanced magnetic resonance imaging.
Kneeshaw PJ; Lowry M; Manton D; Hubbard A; Drew PJ; Turnbull LW
Breast; 2006 Feb; 15(1):29-38. PubMed ID: 16002292
[TBL] [Abstract][Full Text] [Related]
16. Western blotting and enzymatic activity analysis of cathepsin D in breast tissue and sera of patients with breast cancer and benign breast disease and of normal controls.
Schultz DC; Bazel S; Wright LM; Tucker S; Lange MK; Tachovsky T; Longo S; Niedbala S; Alhadeff JA
Cancer Res; 1994 Jan; 54(1):48-54. PubMed ID: 8261461
[TBL] [Abstract][Full Text] [Related]
17. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions.
Stomper PC; Winston JS; Herman S; Klippenstein DL; Arredondo MA; Blumenson LE
Breast Cancer Res Treat; 1997 Aug; 45(1):39-46. PubMed ID: 9285115
[TBL] [Abstract][Full Text] [Related]
19. [Laparoscopic and general surgery guided by open interventional magnetic resonance].
Lauro A; Gould SW; Cirocchi R; Giustozzi G; Darzi A
Minerva Chir; 2004 Oct; 59(5):507-16. PubMed ID: 15494679
[TBL] [Abstract][Full Text] [Related]
20. Physiologic changes in breast magnetic resonance imaging during the menstrual cycle: perfusion imaging, signal enhancement, and influence of the T1 relaxation time of breast tissue.
Delille JP; Slanetz PJ; Yeh ED; Kopans DB; Garrido L
Breast J; 2005; 11(4):236-41. PubMed ID: 15982388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
